Articles from CanSino Biologics Inc

CanSinoBIO Reports Growth in First Nine Months: Commercialization Accelerates Across Multiple Products as Platform Innovation Opens New Avenues for Growth
By CanSino Biologics Inc · Via ACN Newswire · October 27, 2026
Overseas Growth Gathers Momentum as CanSinoBIO's Global Strategy Unlocks New Opportunities
By CanSino Biologics Inc · Via ACN Newswire · August 27, 2026
CanSinoBIO's NDA for Td5cp Adolescent and Adult Accepted, Further Strengthening Its Diversified Vaccine Pipeline
By CanSino Biologics Inc · Via ACN Newswire · August 16, 2026
CanSinoBIO's Menhycia (R) Secures Expanded Age Indication, Unlock Broader Long-Term Growth Potential
By CanSino Biologics Inc · Via ACN Newswire · February 24, 2026